Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma

NCT06907602 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Chemotherapy
DRUG: Immunotherapy (Pembrolizumab)
RADIATION: radiotherapy

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]
[object Object]
[object Object]